Biovica International AB (publ) (BIOVIC-B.ST)
SEK 1.62
(-8.47%)
SEK 1.62
(-8.47%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.14 SEK | 28.19% |
| 2022 | -2.98 SEK | -52.04% |
| 2021 | -1.96 SEK | -51.94% |
| 2020 | -1.29 SEK | -7.5% |
| 2019 | -1.20 SEK | -5.26% |
| 2018 | -1.14 SEK | -11.76% |
| 2017 | -1.02 SEK | -21.43% |
| 2016 | -0.84 SEK | -200.0% |
| 2015 | -0.28 SEK | 30.0% |
| 2014 | -0.40 SEK | 0.0% |
| 2013 | -0.30 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.27 SEK | 42.55% |
| 2023 FY | - SEK | 28.19% |
| 2023 Q3 | -0.44 SEK | 16.98% |
| 2023 Q1 | -0.66 SEK | 14.29% |
| 2023 Q2 | -0.53 SEK | 19.7% |
| 2023 Q4 | -0.47 SEK | -6.82% |
| 2022 Q2 | -0.76 SEK | -2.7% |
| 2022 FY | - SEK | -52.04% |
| 2022 Q4 | -0.77 SEK | -30.51% |
| 2022 Q3 | -0.59 SEK | 22.37% |
| 2022 Q1 | -0.74 SEK | -19.35% |
| 2021 Q2 | -0.50 SEK | -16.28% |
| 2021 FY | - SEK | -51.94% |
| 2021 Q1 | -0.43 SEK | -2.38% |
| 2021 Q4 | -0.62 SEK | -24.0% |
| 2021 Q3 | -0.50 SEK | 0.0% |
| 2020 FY | - SEK | -7.5% |
| 2020 Q2 | -0.29 SEK | 17.14% |
| 2020 Q3 | -0.38 SEK | -31.03% |
| 2020 Q4 | -0.42 SEK | -10.53% |
| 2020 Q1 | -0.35 SEK | 22.22% |
| 2019 Q2 | -0.25 SEK | 3.85% |
| 2019 Q3 | -0.32 SEK | -28.0% |
| 2019 Q1 | -0.26 SEK | 21.21% |
| 2019 FY | - SEK | -5.26% |
| 2019 Q4 | -0.45 SEK | -40.63% |
| 2018 Q1 | -0.23 SEK | -9.52% |
| 2018 FY | - SEK | -11.76% |
| 2018 Q4 | -0.33 SEK | 2.94% |
| 2018 Q3 | -0.34 SEK | -9.68% |
| 2018 Q2 | -0.31 SEK | -34.78% |
| 2017 Q2 | -0.26 SEK | -30.0% |
| 2017 Q1 | -0.20 SEK | 41.18% |
| 2017 FY | - SEK | -21.43% |
| 2017 Q4 | -0.21 SEK | 38.24% |
| 2017 Q3 | -0.34 SEK | -30.77% |
| 2016 Q3 | -0.23 SEK | -53.33% |
| 2016 FY | - SEK | -200.0% |
| 2016 Q4 | -0.34 SEK | -47.83% |
| 2016 Q2 | -0.15 SEK | -25.0% |
| 2016 Q1 | -0.12 SEK | 55.56% |
| 2015 Q4 | -0.27 SEK | 0.0% |
| 2015 Q2 | - SEK | 0.0% |
| 2015 Q1 | - SEK | 0.0% |
| 2015 FY | - SEK | 30.0% |
| 2015 Q3 | -0.27 SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| 2013 FY | - SEK | 0.0% |